Patient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practice

@inproceedings{Syed2014PatientEA,
  title={Patient expectations and experiences of multiple sclerosis interferon β-1a treatment: a longitudinal, observational study in routine UK clinical practice},
  author={Mehmood Syed and David Rog and Laura M. Parkes and Gillian L Shepherd},
  booktitle={Patient preference and adherence},
  year={2014}
}
BACKGROUND Premature discontinuation and poor treatment adherence are problems in chronic conditions, such as multiple sclerosis in which patients must take long-term treatment in order to receive maximum benefit from their medication. The Assessing needs In Multiple Sclerosis (AIMS) study explored factors related to premature treatment discontinuation and patients' experiences of subcutaneous (sc) interferon (IFN) β-1a treatment in the UK. METHODS A questionnaire-based survey was integrated… CONTINUE READING